Controversy Over TB Prize Shows ‘Diplomatic Challenges’ In Combating Disease, WSJ Reports

The Wall Street Journal examines controversy surrounding “the Kochon Prize, a prestigious honor for major contributions to the fight against [tuberculosis (TB)].” The selection committee chose a Tibetan TB program, the newspaper notes. However, the prize recipient must be approved by the WHO director-general, and “the WHO administration, which advises the director-general, didn’t approve the choice because the hospital has ties to the Tibetan government-in-exile,” which is not recognized by the U.N., the newspaper continues. “The controversy reflects the diplomatic challenges the WHO faces as it tries to combat TB and other health problems globally,” the Wall Street Journal writes (McKay, 11/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.